Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson’s disease

References

• Recasens A, Dehay B, Bové J, et al. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol. 2014;75(3):351–362.
   PubMed Web of Science ®Google Scholar
• Yang F, Johansson ALV, Pedersen NL, et al. Socioeconomic status in relation to Parkinson’s disease risk and mortality: a population-based prospective study. Medicine (Baltimore)). 2016;95(30):e4337.
   PubMed Web of Science ®Google Scholar
• Chuang CS, Su HL, Lin CL, et al. Risk of Parkinson disease after organophosphate or carbamate poisoning. Acta Neurol Scand. 2017;136(2):129–137.
   PubMed Web of Science ®Google Scholar
• Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–1601.
   PubMed Web of Science ®Google Scholar
• Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–376.
   PubMed Web of Science ®Google Scholar
• Simpson J, Chatzidamianos G, Fletcher I, et al. A new scale measuring adaptive perceived control for people with Parkinson’s: initial construction and further validation. J Neurol Sci. 2018;391:77–83.
   PubMed Web of Science ®Google Scholar
• Hess CW, Okun MS. Diagnosing Parkinson disease. Continuum. 2016;22(4):1047–1063.
   PubMedGoogle Scholar
• Chevillet JR, Kang Q, Ruf IK, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl AcadSci USA. 2014;111(41):14888–14893.
   PubMed Web of Science ®Google Scholar
• Schneider A, Simons M. Exosomes: vesicular carriers for intercellular commol/Lunication in neurodegenerative disorders. Cell Tissue Res. 2013;352(1):33–47.
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18–30.
   PubMed Web of Science ®Google Scholar
• Soreq L, Salomonis N, Bronstein M, et al. Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes. Front Mol Neurosci. 2013;6:10.
   PubMed Web of Science ®Google Scholar
• Martins M, Rosa A, Guedes LC, et al. Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson’s disease. PLoS One. 2011;6(10):e25443.
   PubMed Web of Science ®Google Scholar
• Hoss AG, Labadorf A, Beach TG, et al. microRNA profiles in Parkinson’s disease prefrontal cortex. Front Aging Neurosci. 2016;8:36.
   PubMed Web of Science ®Google Scholar
• Ding H, Huang Z, Chen M, et al. Identification of a panel of five serum miRNAs as a biomarker for Parkinson’s disease. Parkinsonism Relat Disord. 2016;22:68–73.
   PubMed Web of Science ®Google Scholar
• Ma W, Li Y, Wang C, et al. Serum miR-221 serves as a biomarker for Parkinson's disease. Cell Biochem Funct. 2016;34(7):511–515.
   PubMed Web of Science ®Google Scholar
• Burgos K, Malenica I, Metpally R, et al. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson’s diseases correlate with disease status and features of pathology. PLoS One. 2014;9(5):e94839.
   PubMed Web of Science ®Google Scholar
• Park SH, Goo JM, Jo CH. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol. 2004;5(1):11–18.
   PubMed Web of Science ®Google Scholar
• Meretoja TJ, Andersen KG, Bruce J, et al. Clinical prediction model and tool for assessing risk of persistent pain after breast cancer surgery. J Cin Oncol. 2017;35(15):1660–1667.
   PubMed Web of Science ®Google Scholar
• Heringlake M, Charitos EI, Erber K, et al. Preoperative plasma growth-differentiation factor-15 for prediction of acute kidney injury in patients undergoing cardiac surgery. Crit Care. 2016;20(1):317.
   PubMed Web of Science ®Google Scholar
• Matoušková P, Hanousková B, Skálová L. MicroRNAs as potential regulators of glutathione peroxidases expression and their role in obesity and related pathologies. Int J Mol Sci. 2018;19:1199.
   PubMed Web of Science ®Google Scholar
• ElHefnawi M, Soliman B, Abu-Shahba N, et al. An integrative meta-analysis of microRNAs in hepatocellular carcinoma. Genomics Proteomics Bioinformatics. 2013;11(6):354–367.
   PubMedGoogle Scholar
• Kosciuczuk EM, Mehrotra S, Saleiro D, et al. Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses. J Biol Chem. 2018;294:827–837.
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology, the gene ontology consortium. Nat Genet. 2000;25(1):25–29.
   PubMed Web of Science ®Google Scholar
• Wu J, Mao X, Cai T, et al. KOBAS server: a web-based platform for automated annotation and pathway identification. Nucleic Acids Res. 2006;34:W720–W72 4.
   PubMed Web of Science ®Google Scholar
• Ai C, Kong L. CGPS: a machine learning-based approach integrating multiple gene set analysis tools for better prioritization of biologically relevant pathways. J Genet Genomics. 2018;45(9):489–504.
   PubMed Web of Science ®Google Scholar
• Marques TM, Kuiperij HB, Bruinsma IB, et al. MicroRNAs in cerebrospinal fluid as potential biomarkers for Parkinson’s disease and multiple system atrophy. Mol Neurobiol. 2017;54(10):7736–7745.
   PubMed Web of Science ®Google Scholar
• Fritz NE, Kegelmeyer DA, Kloos AD, et al. Motor performance differentiates individuals with Lewy body dementia, Parkinson’s and Alzheimer’s disease. Gait Posture. 2016;50:1–7.
   PubMed Web of Science ®Google Scholar
• Liu F, Vermesh O, Mani V, et al. The exosome total isolation chip. ACS Nano. 2017;11(11):10712–10723.
   PubMed Web of Science ®Google Scholar
• Shao H, Im H, Castro CM, et al. New technologies for analysis of extracellular vesicles. Chem Rev. 2018;118(4):1917–1950.
   PubMed Web of Science ®Google Scholar
• Coumans FAW, Brisson AR, Buzas EI, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017;120(10):1632–1648.
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
   PubMed Web of Science ®Google Scholar
• Stevanato L, Thanabalasundaram L, Vysokov N, et al. Investigation of content, stoichiometry and transfer of miRNA from human neural stem cell line derived exosomes. PLoS One. 2016;11(1):e0146353.
   PubMed Web of Science ®Google Scholar
• Li P, Kaslan M, Lee SH, et al. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789–804.
   PubMed Web of Science ®Google Scholar
• Xicoy H, Wieringa B, Martens GJ. The SH-SY5Y cell line in Parkinson’s disease research: a systematic review. Mol Neurodegener. 2017;12:10.
   PubMed Web of Science ®Google Scholar
• van der Merwe C, van Dyk HC, Engelbrecht L, et al. Curcumin rescues a PINK1 knock down SH-SY5Y cellular model of Parkinson’s disease from mitochondrial dysfunction and cell death. Mol Neurobiol. 2017;54(4):2752–2762.
   PubMed Web of Science ®Google Scholar
• Krishna A, Biryukov M, Trefois C, et al. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson’s disease. BMC Genomics. 2014;15:1154.
   PubMed Web of Science ®Google Scholar
• Gong P, Deng F, Zhang W, et al. Tectorigenin attenuates the MPP-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson’s disease by oxidative stress inhibition. Exp Ther Med. 2017;14(5):4431–4437.
   PubMed Web of Science ®Google Scholar
• Lan YL, Zhou JJ, Liu J, et al. Uncaria rhynchophylla Ameliorates Parkinson’s disease by inhibiting HSP90 expression: insights from quantitative proteomics. Cell Physiol Biochem. 2018;47(4):1453–1464.
   PubMedGoogle Scholar
• Eum WS, Shin MJ, Lee CH, et al. Neuroprotective effects of Tat-ATOX1 protein against MPP-induced SH-SY5Y cell deaths and in MPTP-induced mouse model of Parkinson’s disease. Biochimie. 2019;156:158–168.
   PubMed Web of Science ®Google Scholar
• Shi M, Liu C, Cook TJ, et al. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease. Acta Neuropathol. 2014;128(5):639–650.
   PubMed Web of Science ®Google Scholar
• Török N, Majláth Z, Szalárdy L, et al. Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease. Expert Opin Investig Drugs. 2016;25(11):1281–1294.
   PubMed Web of Science ®Google Scholar
• Emelyanov A, Kulabukhova D, Garaeva L, et al. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson’s disease. J Neurol Sci. 2018;395:135–140.
   PubMed Web of Science ®Google Scholar
• Zucca FA, Segura-Aguilar J, Ferrari E, et al. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson’s disease. Prog Neurobiol. 2017;155:96–119.
   PubMed Web of Science ®Google Scholar
• Segura-Aguilar J, Paris I, Muñoz P, et al. Protective and toxic roles of dopamine in Parkinson’s disease. J Neurochem. 2014;129(6):898–915.
   PubMed Web of Science ®Google Scholar
• Matsumoto M. Dopamine signals and physiological origin of cognitive dysfunction in Parkinson’s disease. Mov Disord. 2015;30(4):472–483.
   PubMed Web of Science ®Google Scholar
• Szadejko K, Dziewiatowski K, Szabat K, et al. Polyneuropathy in levodopa-treated Parkinson’s patients. J Neurol Sci. 2016;371:36–41.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lian YJ, Ma YQ, et al. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells. Neurotoxicology. 2018;68:212–221.
   PubMed Web of Science ®Google Scholar